Case number 1:24-cv-00043
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc. > Summary
Court Case Number 1:24-cv-00043
Filing Date Jan 11, 2024
Court Delaware District Court
Status Unknown
JudgesWilliam C. Bryson
Plaintiff
Defendant
Plaintiff Attorneys
7Heron Therapeutics, Inc.
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
Heron Therapeutics, Inc.
Attorney Name: Bruce M. Wexler
Paul Hastings
Heron Therapeutics, Inc.
Attorney Name: Christopher P. Hill
Paul Hastings
Heron Therapeutics, Inc.
Attorney Name: Isaac S. Ashkenazi
Paul Hastings
Heron Therapeutics, Inc.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
Heron Therapeutics, Inc.
Attorney Name: Mark Russell Sperling
Paul Hastings
Defendant Attorneys
Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11744800 | Methods of use of emulsion formulations of an NK-1 receptor antagonist | Sep 5, 2023 |
| 11173118 | Emulsion formulations of an NK-1 receptor antagonist and uses thereof | Nov 16, 2021 |
| 10953018 | Emulsion formulations of aprepitant | Mar 23, 2021 |
| 10624850 | Emulsion formulations of an NK-1 receptor antagonist and uses thereof | Apr 21, 2020 |
| 10500208 | Emulsion formulations of aprepitant | Dec 10, 2019 |
| 09974742 | Emulsion formulations of an NK-1 receptor antagonist and uses thereof | May 22, 2018 |
| 09974793 | Emulsion formulations of aprepitant | May 22, 2018 |
| 09974794 | Emulsion formulations of aprepitant | May 22, 2018 |
| 09808465 | Emulsion formulations of aprepitant | Nov 7, 2017 |
| 09561229 | Emulsion formulations of aprepitant | Feb 7, 2017 |
